In 1983, sp. strain 1220 was isolated in Hungary from the phallus lymph of a gander with phallus inflammation. Between 1983 and 2017, sp. 1220 was also identified and isolated from the respiratory tract, liver, ovary, testis, peritoneum and cloaca of diseased geese in several countries. Seventeen studied strains produced acid from glucose and fructose but did not hydrolyse arginine or urea, and all grew under aerobic, microaerophilic and anaerobic conditions at 35 to 37 ˚C in either SP4 or pleuropneumonia-like organism medium supplemented with glucose and serum. Colonies on agar showed a typical fried-egg appearance and transmission electron microscopy revealed a typical mycoplasma cellular morphology. Molecular characterization included analysis of the following genetic loci: 16S rRNA, 23S rRNA, 16S-23S rRNA ITS, , , , , , , , and . The genome was sequenced for type strain 1220. The 16S rRNA gene sequences of studied strains of sp. 1220 shared 99.02-99.19 % nucleotide similarity with strains but demonstrated ≤95.00-96.70 % nucleotide similarity to the 16S rRNA genes of other species of the genus . Phylogenetic, average nucleotide and amino acid identity analyses revealed that the novel species was most closely related to . Based on the genetic data, we propose a novel species of the genus , for which the name sp. nov. is proposed with the type strain 1220 (=ATCC BAA-2147=NCTC 13513=DSM 23982). The G+C content is 26.70 mol%, genome size is 959110 bp.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1099/ijsem.0.004052 | DOI Listing |
EClinicalMedicine
January 2025
Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Background: The impact of pre-infection vaccination on the risk of long COVID remains unclear in the pediatric population. We aim to assess the effectiveness of BNT162b2 on long COVID risks with various strains of the SARS-CoV-2 virus in children and adolescents, using comparative effectiveness methods. We further explore if such pre-infection vaccination can mitigate the risk of long COVID beyond its established protective benefits against SARS-CoV-2 infection using causal mediation analysis.
View Article and Find Full Text PDFACS Appl Mater Interfaces
January 2025
Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.
A biofuel cell is an electrochemical device using exoelectrogen or biocatalysts to transfer electrons from redox reactions to the electrodes. While wild-type microbes and natural enzymes are often employed as exoelectrogen and biocatalysts, genetically engineered or modified organisms have been developed to enhance exoelectrogen activity. Here, we demonstrated a redox-enzyme integrated microbial fuel cell (REI-MFC) design based on an exoelectrogen-enhancing strategy that reinforces the electrogenic activity of MR1 by displaying an extra redox enzyme on the cell surface.
View Article and Find Full Text PDFACS Appl Mater Interfaces
November 2024
Shenzhen Intern ational Graduate School, Tsinghua University, Shenzhen 518055, China.
BMC Infect Dis
October 2024
Departman of Veterinary Microbiology, Fakulty of Veterinary Medicine, Harran University, Şanlıurfa, Türkiye.
Folia Microbiol (Praha)
October 2024
Microbiology and Immunology Department, Faculty of Pharmacy, Port Said University, Port Said, Egypt.
The spread of multidrug-resistant Escherichia coli in healthcare facilities is a global challenge. Hospital-acquired infections produced by Escherichia coli include gastrointestinal, blood-borne, urinary tract, surgical sites, and neonatal infections. Therefore, novel approaches are needed to deal with this pathogen and its rising resistance.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!